ArticleFrontiers in cardiovascular medicine2026
Relapsing allergic bronchopulmonary aspergillosis as a trigger for Kounis syndrome: a case report.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kounis syndrome is an allergic acute coronary syndrome triggered by hypersensitivity reactions. Its association with allergic bronchopulmonary aspergillosis (ABPA) is rarely reported. We describe a 77-year-old woman with asthma, chronic obstructive pulmonary disease, and established ABPA who developed acute chest tightness and dyspnea during an ABPA relapse. Laboratory testing showed marked eosinophilia, elevated total IgE, and evidence of myocardial injury, with increased cardiac troponin I and B-type natriuretic peptide. Electrocardiography revealed ischemic changes, and coronary angiography demonstrated nonobstructive coronary arteries. Based on the clinical and immunologic findings, Kounis syndrome, possibly triggered by ABPA, was diagnosed. The patient improved with antifungal therapy, systemic corticosteroids, coronary vasodilators, and supportive care. This case highlights ABPA relapse as a potential trigger of Kounis syndrome and emphasizes the need for cardiovascular vigilance in patients with severe allergic airway disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.